financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Oracle Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Oracle Corporation
Jun 12, 2025 9:13 AM

11:55 AM EDT, 06/12/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our 12-month target price to $215 from $185, on a higher revised P/E of 29x our CY 26 EPS estimate of $7.42, within software peers but above historical. This reflects improving visibility and accelerating growth potential tied to the cloud and AI. After posting better-than-expected May-Q results, we keep our FY 26 (May) EPS estimate at $6.71 and start FY 27's estimate at $8.01. We come away extremely impressed by ORCL's improved visibility and commentary about very high customer demand, as we note that RPO is expected to more than double in the year ahead as momentum builds across what we view as ORCL's three core growth engines - AI infrastructure builds (IaaS), strategic SaaS, and Database Multi-Cloud growth (through partnerships from other hyperscalers). Despite rising capex needs (increasing to at least $25B in FY 26 from $21B in FY 25 and $6.9B in FY 24) that will likely constrain FCF generation in the near term and large net debt position ($81B), growth prospects are too enticing to ignore.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cvs Health Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cvs Health Corporation
Nov 11, 2025
11:45 AM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price by $17, to $85, valuing CVS shares at 10.6x our newly initiated 2027 EPS estimate of $8.05 and at 11.9x our 2026 EPS estimate...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Hyatt Hotels Corporation
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Hyatt Hotels Corporation
Nov 11, 2025
01:00 PM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $16 to $174, based on a 2026 EV/EBITDA multiple of 14x (unchanged) vs. its 12x-15x three-year trading range. We lower our 2025 EPS estimate...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Canada Goose; Raises Price Target
Research Alert: CFRA Maintains Buy Opinion On Shares Of Canada Goose; Raises Price Target
Nov 11, 2025
11:55 AM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by CAD4 to CAD20, based on 18x our FY 26 EPS estimate and in line with the company's three-year average forward P/E multiple. This...
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Cigna Group
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Cigna Group
Nov 11, 2025
01:10 PM EST, 11/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price of $310, valuing the shares at 9.1x our newly introduced 2027 EPS estimate of $33.90 and at 10x our 2026 EPS estimate of $30.85...
Copyright 2023-2026 - www.financetom.com All Rights Reserved